A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts
2005

MR-4: A Potent Resveratrol Derivative Inducing Cancer Cell Death

publication Evidence: moderate

Author Information

Author(s): Gosslau A, Chen M, Ho Ci-T, Chen K Y

Primary Institution: Rutgers, The State University of New Jersey

Hypothesis

Can the methoxy derivative of resveratrol selectively induce apoptosis in transformed cells while sparing normal cells?

Conclusion

The study found that MR-4 selectively induced apoptosis in transformed cells without affecting normal cells.

Supporting Evidence

  • MR-4 was found to be 100-fold more potent than R-3 in inhibiting the growth of transformed cells.
  • MR-4 induced significant DNA fragmentation in transformed cells, indicating apoptosis.
  • The Bax/Bcl-2 ratio increased in transformed cells after MR-4 treatment, suggesting activation of apoptotic pathways.

Takeaway

MR-4 is a special version of resveratrol that can kill cancer cells but not normal cells, making it a potential cancer treatment.

Methodology

The study used various human cell lines to compare the effects of MR-4 and R-3 on cell growth and apoptosis.

Limitations

The study primarily focused on in vitro models, and further research is needed to assess toxicity and efficacy in vivo.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602300

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication